Anesthesia, General Clinical Trial
— PUPIL_painOfficial title:
Effect of Pupilometer Guided Analgesia on Postoperative Pain Intensity and Perioperative Complications
NCT number | NCT03794271 |
Other study ID # | DCMC#6 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 3, 2019 |
Est. completion date | May 10, 2019 |
Verified date | August 2019 |
Source | Daegu Catholic University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study, the investigators measure a pupil size every 5 minutes during the operation in patients undergoing laparoscopic cholecystectomy under general anesthesia. The investigators would compare the postoperative pain intensity between the group adjusted the anesthetic drug concentration based on the changes of the pupil (Pupil group) and the group based on the changes of a surgical pleth index (SPI group).
Status | Completed |
Enrollment | 84 |
Est. completion date | May 10, 2019 |
Est. primary completion date | May 9, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Patients aged 20 to 65 yr, American Society of Anesthesiologist Physical status(ASA PS) I to II, scheduled for a laparoscopic cholecystectomy under general anesthesia Exclusion Criteria: - Presence of ophthalmologic diseases such as Horner's syndrome or Sjogren's disease. - Presence of neurologic or metabolic diseases - Medicated that could interfere with the autonomous nervous system (e.g., b- blockers, anticholinergics) - History of substance abuse or psychiatric disease with chronic pain or preoperative analgesics with pacemaker or arrhythmia |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Eugene Kim | Daegu | Nam-gu |
Lead Sponsor | Collaborator |
---|---|
Daegu Catholic University Medical Center |
Korea, Republic of,
Huybrechts I, Barvais L, Ducart A, Engelman E, Schmartz D, Koch M. Assessment of thoracic epidural analgesia during general anesthesia using pupillary reflex dilation: a preliminary study. J Cardiothorac Vasc Anesth. 2006 Oct;20(5):664-7. Epub 2006 Aug 8. — View Citation
Larson MD, Behrends M. Portable infrared pupillometry: a review. Anesth Analg. 2015 Jun;120(6):1242-53. doi: 10.1213/ANE.0000000000000314. Review. — View Citation
Ledowski T, Burke J, Hruby J. Surgical pleth index: prediction of postoperative pain and influence of arousal. Br J Anaesth. 2016 Sep;117(3):371-4. doi: 10.1093/bja/aew226. — View Citation
Neice AE, Behrends M, Bokoch MP, Seligman KM, Conrad NM, Larson MD. Prediction of Opioid Analgesic Efficacy by Measurement of Pupillary Unrest. Anesth Analg. 2017 Mar;124(3):915-921. doi: 10.1213/ANE.0000000000001728. — View Citation
Sabourdin N, Barrois J, Louvet N, Rigouzzo A, Guye ML, Dadure C, Constant I. Pupillometry-guided Intraoperative Remifentanil Administration versus Standard Practice Influences Opioid Use: A Randomized Study. Anesthesiology. 2017 Aug;127(2):284-292. doi: 10.1097/ALN.0000000000001705. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | PACU stay time | Duration of time interval from PACU admission to discharge. | Approximately within 1 hour after the PACU admission | |
Other | Intraoperative vasopressor or vasodilator consumption | The amount of ephedrine and nicardipine consumption during the operation | During the operation period (Within 2 hour after the anesthesia induction) | |
Primary | Peak pain score assessed by numeric rating scale (NRS) in post-anesthesia care unit (PACU) | Patients are asked to rate their pain according to the numeric rating scale (NRS, 0=no pain to 10= extreme pain imaginable) every 10 min after the PACU admission. Peak pain score is the peak NRS during PACU stay. Higher NRS represents a worse outcome. | During the PACU stay (Within 1 hour after the PACU admission) | |
Secondary | Intraoperative remifentanil consumption rate | The amount of remifentanil consumption during the operation is calculated by following equation: Total remifentanil consumption (mcg) / body weight of the patients (kg)/ duration of anesthesia (min) |
During the operation period (Within 2 hour after the anesthesia induction) | |
Secondary | Postoperative adverse events | Check the postoperative nausea and vomiting, dizziness, desaturation, urinary retention, itching sensation and bradycardia | Approximately within 1 hour after the PACU admission | |
Secondary | Remnant sedation degree | Remnant sedation is evaluated by Riker Sedation-Agitation (RSA) Scale every 10 minutes after the PACU admission. unarousable, minimal or no response to noxious stimuli, does not communicate of follow commands very sedate, arouse to physical stimuli but does not communicate or follow command, may move spontaneously sedate, difficult to arouse but awakens to verbal stimuli or gentle shaking, follows simple commands but drifts off again Calm and cooperative, calm and follows commands agitated, anxious or physically agitated and calms to verbal instructions very agitated, requiring restraint and frequent verbal reminding of limits, biting endotracheal tubes dangerous agitation, pulling at tracheal tube, trying to remove catheters or striking at staff RSA scale 4 means normal. If the RSA <4, it means the patients are sedated. If the RSA >5, it means the patients are agitated. |
Approximately within 1 hour after the PACU admission | |
Secondary | Pain score assessed by numeric rating scale (NRS) 1 day after the operation | Patients are asked to rate their pain according to the numeric rating scale (NRS, 0=no pain to 10= extreme pain imaginable) 1 day after the operation. Higher NRS represents a worse outcome. | On 1 day after the operation | |
Secondary | Total analgesic consumption after PACU discharge | Check the analgesic consumption after PACU discharge including oral, intramuscular and intravenous administration. | During 1 day after the operation | |
Secondary | Intraoperative propofol consumption | The amount of propofol consumption during the operation | During the operation period (Within 2 hour after the anesthesia induction) | |
Secondary | Intraoperative mean SPI | Check the SPI value throughout the operation using the vital recorder program. | Approximately during 2 hour after the anesthesia induction |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06063798 -
Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery
|
N/A | |
Not yet recruiting |
NCT05035069 -
Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR
|
Phase 4 | |
Completed |
NCT03861364 -
Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose.
|
Phase 4 | |
Completed |
NCT02711280 -
The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children
|
N/A | |
Completed |
NCT01199471 -
Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane
|
N/A | |
Completed |
NCT00917033 -
Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy
|
Phase 4 | |
Completed |
NCT00391885 -
Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy
|
Phase 4 | |
Completed |
NCT00552617 -
A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)
|
Phase 2 | |
Completed |
NCT03705026 -
Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
|
||
Completed |
NCT00552929 -
A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974)
|
Phase 2 | |
Completed |
NCT00298831 -
Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)
|
Phase 3 | |
Completed |
NCT00475215 -
Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)
|
Phase 3 | |
Recruiting |
NCT03943745 -
EEG Changes During Induction of Propofol Anesthesia
|
||
Completed |
NCT03697642 -
Nasopharyngeal Airway Guide Nasogastric Tube Placement
|
N/A | |
Completed |
NCT04595591 -
Observation of Propofol Titration at Different Speeds
|
N/A | |
Not yet recruiting |
NCT05841316 -
The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
|
||
Completed |
NCT04532502 -
Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
|
||
Completed |
NCT03330236 -
EEG - Guided Anesthetic Care and Postoperative Delirium
|
N/A | |
Recruiting |
NCT06205212 -
High-flow Nasal Oxygenation During Preoxygenation and Atelectasis
|
N/A | |
Completed |
NCT00379613 -
Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)
|
Phase 2 |